Press Release|Articles|October 22, 2025

Uniting for Progress: Highlights from the PanCAN Scientific Summit and AACR Pancreatic Cancer Conference

Listen
0:00 / 0:00

Key Takeaways

  • The PanCAN Summit and AACR Conference emphasized collaboration and innovation in pancreatic cancer research, focusing on early detection, biomarkers, immunotherapy, and KRAS-targeted treatments.
  • Emerging technologies like artificial intelligence and big data are pivotal in understanding pancreatic tumors and identifying optimal patient therapies.
SHOW MORE

Each year, the PanCAN Scientific Summit brings together some of the brightest minds in pancreatic cancer research.

Each year, the PanCAN Scientific Summit brings together some of the brightest minds in pancreatic cancer research — scientists, clinicians, industry partners, and advocates — all driven by a shared mission, to improve outcomes and bring hope to patients and families. This year’s Summit was more than just a meeting of experts; it was a celebration of collaboration, innovation, and progress. The energy in the room was unmistakable, fueled by a deep commitment to push the science forward, even as federal research funding faces uncertainty.

Throughout the event, participants shared the latest findings across the pancreatic cancer landscape from early detection strategies and biomarker discoveries to promising advances in immunotherapy and KRAS-targeted treatments. Attendees also explored how emerging tools like artificial intelligence and big data are opening new doors to understanding pancreatic tumors and identifying which patients might benefit most from certain therapies.

Following the Summit, members of the PanCAN team joined colleagues from around the world at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer. This gathering expanded the global conversation, spotlighting cutting-edge work from academic and industry leaders alike. Presentations covered key themes such as overcoming treatment resistance, understanding the tumor microenvironment, and finding new ways to detect pancreatic cancer earlier, when it’s most treatable.

Together, these two events underscored a powerful truth: progress in pancreatic cancer happens when collaboration meets purpose. The dedication of researchers, clinicians, and advocates around the world continues to move the field forward, one discovery, one partnership, one patient at a time.

To explore the scientific highlights and key takeaways from both meetings, read the latest Research Spotlight from Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer: https://pancan.org/news/research-spotlight/research-spotlight-building-momentum-and-hope-reflections-on-pancans-2025-scientific-summit-and-aacr-pancreatic-cancer-conference/

Newsletter

Stay up to date on cancer updates, research and education